Lau YK - Search Results

1

Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma.

Xia W, Lau YK, Zhang HZ, Liu AR, Li L, Kiyokawa N, Clayman GL, Katz RL, Hung MC. Xia W, et al. Among authors: lau yk. Clin Cancer Res. 1997 Jan;3(1):3-9. Clin Cancer Res. 1997. PMID: 9815530

2

Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.

Zhang L, Lau YK, Xia W, Hortobagyi GN, Hung MC. Zhang L, et al. Among authors: lau yk. Clin Cancer Res. 1999 Feb;5(2):343-53. Clin Cancer Res. 1999. PMID: 10037184

3

Basic science of HER-2/neu: a review.

Hung MC, Lau YK. Hung MC, et al. Among authors: lau yk. Semin Oncol. 1999 Aug;26(4 Suppl 12):51-9. Semin Oncol. 1999. PMID: 10482194 Review.

4

Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members.

Xia W, Lau YK, Zhang HZ, Xiao FY, Johnston DA, Liu AR, Li L, Katz RL, Hung MC. Xia W, et al. Among authors: lau yk. Clin Cancer Res. 1999 Dec;5(12):4164-74. Clin Cancer Res. 1999. PMID: 10632356

5

High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma.

Xia W, Lau YK, Hu MC, Li L, Johnston DA, Sheng Sj, El-Naggar A, Hung MC. Xia W, et al. Among authors: lau yk. Oncogene. 2000 May 11;19(20):2398-403. doi: 10.1038/sj.onc.1203535. Oncogene. 2000. PMID: 10828881

6

Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties.

Zhang L, Lau YK, Xi L, Hong RL, Kim DS, Chen CF, Hortobagyi GN, Chang C, Hung MC. Zhang L, et al. Among authors: lau yk. Oncogene. 1998 Jun 4;16(22):2855-63. doi: 10.1038/sj.onc.1201813. Oncogene. 1998. PMID: 9671406

7

Overexpression of lysyl oxidase to increase matrix crosslinking and improve tissue strength in dermal wound healing.

Lau YK, Gobin AM, West JL. Lau YK, et al. Ann Biomed Eng. 2006 Aug;34(8):1239-46. doi: 10.1007/s10439-006-9130-8. Epub 2006 Jun 28. Ann Biomed Eng. 2006. PMID: 16804742

8

A General Pd-Catalyzed C2-H Arylation of Benzoxazoles with Highly Sterically Congested Aryl Chlorides Enabled by a Fittingly Tuned Ligand.

Song W, Tse MH, Lau YK, Cheung CW, Choy PY, Kwong FY. Song W, et al. Among authors: lau yk. Org Lett. 2024 Dec 20;26(50):10958-10963. doi: 10.1021/acs.orglett.4c04117. Epub 2024 Dec 6. Org Lett. 2024. PMID: 39642112

9

Bias due to coarsening of time intervals in the inference for the effectiveness of colorectal cancer screening.

Karmakar B, Zauber AG, Hahn AI, Lau YK, Doubeni CA, Joffe MM. Karmakar B, et al. Among authors: lau yk. Int J Epidemiol. 2024 Jun 12;53(4):dyae096. doi: 10.1093/ije/dyae096. Int J Epidemiol. 2024. PMID: 39002174

10

Evaluation of tendon and ligament microstructure and mechanical properties in a canine model of mucopolysaccharidosis I.

Lau YK, Iyer K, Shetye S, Friday CS, Dodge GR, Hast MW, Casal ML, Gawri R, Smith LJ. Lau YK, et al. J Orthop Res. 2024 Jul;42(7):1409-1419. doi: 10.1002/jor.25813. Epub 2024 Feb 18. J Orthop Res. 2024. PMID: 38368531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters